← Open Payments lookup

ELISA SALAZAR: Open Payments

NPI 1225359961 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,909 in 83 payments from 16 companies in 2025. Trend: 2023 $790 · 2024 $1,258 · 2025 $1,909

Food & beverage: $1,909
CompanyPaymentsAmount
ABBVIE INC.22$314
Otsuka America Pharmaceutical, Inc.9$237
E.R. Squibb & Sons, L.L.C.7$213
Axsome Therapeutics, Inc.6$213
Neurocrine BioSciences, Inc.3$177
Janssen Pharmaceuticals, Inc4$174
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$142
Teva Pharmaceuticals USA, Inc.4$91
Corium, LLC5$75
Tris Pharma Inc3$62

Products named: VRAYLAR, COBENFY, Auvelity, INGREZZA, SPRAVATO, CAPLYTA, ABILIFY MAINTENA, REXULTI.

Industry payments across ID — which companies pay providers there.